Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
651 | 3208 | 59.2 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
497 | 3 | CANNABINOID//ANANDAMIDE//ENDOCANNABINOIDS | 22707 |
535 | 2 | CANNABINOID//ENDOCANNABINOIDS//ANANDAMIDE | 14838 |
651 | 1 | CANNABINOID//CB1 RECEPTOR//ENDOCANNABINOIDS | 3208 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CANNABINOID | authKW | 1837275 | 26% | 23% | 823 |
2 | CB1 RECEPTOR | authKW | 1141157 | 9% | 43% | 282 |
3 | ENDOCANNABINOIDS | authKW | 897224 | 13% | 23% | 404 |
4 | SR141716A | authKW | 645388 | 4% | 52% | 131 |
5 | WIN 55 212 2 | authKW | 497237 | 3% | 49% | 106 |
6 | ANANDAMIDE | authKW | 468534 | 8% | 19% | 262 |
7 | DELTA9 TETRAHYDROCANNABINOL | authKW | 452881 | 4% | 37% | 130 |
8 | CANNABINOID CB1 RECEPTOR | authKW | 330767 | 2% | 45% | 78 |
9 | CB1 | authKW | 319131 | 4% | 29% | 117 |
10 | CANNABINOID RECEPTORS | authKW | 311472 | 6% | 18% | 186 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 46773 | 69% | 0% | 2211 |
2 | Pharmacology & Pharmacy | 17284 | 43% | 0% | 1387 |
3 | Psychiatry | 8096 | 19% | 0% | 603 |
4 | Behavioral Sciences | 6717 | 11% | 0% | 342 |
5 | Substance Abuse | 1626 | 4% | 0% | 113 |
6 | Clinical Neurology | 496 | 7% | 0% | 223 |
7 | Physiology | 166 | 4% | 0% | 113 |
8 | Medicine, Research & Experimental | 22 | 2% | 0% | 72 |
9 | Psychology, Biological | 19 | 0% | 0% | 13 |
10 | Psychology | 9 | 1% | 0% | 27 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PRECLIN PHARMACOL SECT | 128588 | 2% | 26% | 52 |
2 | COMPLUTENSE DROGODEPENDENCIAS | 114878 | 0% | 93% | 13 |
3 | UNIV DROGODEPENDENCIAS | 88575 | 0% | 85% | 11 |
4 | ANALYT PSYCHOPHARMACOL | 86955 | 1% | 32% | 29 |
5 | IMPAIRMENT STUDY | 80605 | 0% | 71% | 12 |
6 | BB BRODIE NEUROSCI | 74389 | 1% | 21% | 37 |
7 | DBSF | 72247 | 1% | 29% | 26 |
8 | NEURO MAGENDIE ENDOCANNABINOIDS NEUROAD TAT | 58288 | 0% | 88% | 7 |
9 | IRANIAN ADDICT STUDIES | 56830 | 1% | 16% | 37 |
10 | FISIOL FISIOL ANIM 2 | 49931 | 1% | 25% | 21 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BEHAVIOURAL PHARMACOLOGY | 28982 | 2% | 4% | 77 |
2 | PSYCHOPHARMACOLOGY | 25359 | 6% | 2% | 180 |
3 | NEUROPSYCHOPHARMACOLOGY | 19395 | 3% | 2% | 102 |
4 | NEUROPHARMACOLOGY | 18372 | 4% | 1% | 135 |
5 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 12209 | 4% | 1% | 127 |
6 | ADDICTION BIOLOGY | 9745 | 1% | 3% | 35 |
7 | JOURNAL OF NEUROSCIENCE | 6741 | 5% | 0% | 157 |
8 | EUROPEAN JOURNAL OF PHARMACOLOGY | 6643 | 4% | 1% | 142 |
9 | EUROPEAN JOURNAL OF NEUROSCIENCE | 5966 | 3% | 1% | 84 |
10 | BEHAVIOURAL BRAIN RESEARCH | 5146 | 2% | 1% | 76 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANNABINOID | 1837275 | 26% | 23% | 823 | Search CANNABINOID | Search CANNABINOID |
2 | CB1 RECEPTOR | 1141157 | 9% | 43% | 282 | Search CB1+RECEPTOR | Search CB1+RECEPTOR |
3 | ENDOCANNABINOIDS | 897224 | 13% | 23% | 404 | Search ENDOCANNABINOIDS | Search ENDOCANNABINOIDS |
4 | SR141716A | 645388 | 4% | 52% | 131 | Search SR141716A | Search SR141716A |
5 | WIN 55 212 2 | 497237 | 3% | 49% | 106 | Search WIN+55+212+2 | Search WIN+55+212+2 |
6 | ANANDAMIDE | 468534 | 8% | 19% | 262 | Search ANANDAMIDE | Search ANANDAMIDE |
7 | DELTA9 TETRAHYDROCANNABINOL | 452881 | 4% | 37% | 130 | Search DELTA9+TETRAHYDROCANNABINOL | Search DELTA9+TETRAHYDROCANNABINOL |
8 | CANNABINOID CB1 RECEPTOR | 330767 | 2% | 45% | 78 | Search CANNABINOID+CB1+RECEPTOR | Search CANNABINOID+CB1+RECEPTOR |
9 | CB1 | 319131 | 4% | 29% | 117 | Search CB1 | Search CB1 |
10 | CANNABINOID RECEPTORS | 311472 | 6% | 18% | 186 | Search CANNABINOID+RECEPTORS | Search CANNABINOID+RECEPTORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MORENA, M , PATEL, S , BAINS, JS , HILL, MN , (2016) NEUROBIOLOGICAL INTERACTIONS BETWEEN STRESS AND THE ENDOCANNABINOID SYSTEM.NEUROPSYCHOPHARMACOLOGY. VOL. 41. ISSUE 1. P. 80 -102 | 152 | 59% | 20 |
2 | HASHIMOTODANI, Y , UCHIGASHIMA, M , WATANABE, M , KANO, M , OHNO-SHOSAKU, T , (2009) ENDOCANNABINOID-MEDIATED CONTROL OF SYNAPTIC TRANSMISSION.PHYSIOLOGICAL REVIEWS. VOL. 89. ISSUE 1. P. 309 -380 | 245 | 43% | 502 |
3 | SERRANO, A , PARSONS, LH , (2011) ENDOCANNABINOID INFLUENCE IN DRUG REINFORCEMENT, DEPENDENCE AND ADDICTION-RELATED BEHAVIORS.PHARMACOLOGY & THERAPEUTICS. VOL. 132. ISSUE 3. P. 215-241 | 286 | 55% | 44 |
4 | PANLILIO, LV , JUSTINOVA, Z , GOLDBERG, SR , (2013) INHIBITION OF FAAH AND ACTIVATION OF PPAR: NEW APPROACHES TO THE TREATMENT OF COGNITIVE DYSFUNCTION AND DRUG ADDICTION.PHARMACOLOGY & THERAPEUTICS. VOL. 138. ISSUE 1. P. 84 -102 | 190 | 61% | 31 |
5 | PARSONS, LH , HURD, YL , (2015) ENDOCANNABINOID SIGNALLING IN REWARD AND ADDICTION.NATURE REVIEWS NEUROSCIENCE. VOL. 16. ISSUE 10. P. 579 -594 | 131 | 66% | 21 |
6 | ZANETTINI, C , PANLILIO, LV , ALICKI, M , GOLDBERG, SR , HALLER, J , YASAR, S , (2011) EFFECTS OF ENDOCANNABINOID SYSTEM MODULATION ON COGNITIVE AND EMOTIONAL BEHAVIOR.FRONTIERS IN BEHAVIORAL NEUROSCIENCE. VOL. 5. ISSUE . P. - | 125 | 82% | 59 |
7 | SIDHPURA, N , PARSONS, LH , (2011) ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY AND ADDICTION-RELATED BEHAVIOR.NEUROPHARMACOLOGY. VOL. 61. ISSUE 7. P. 1070 -1087 | 200 | 53% | 26 |
8 | LOPEZ-MORENO, JA , GONZALEZ-CUEVAS, G , MORENO, G , NAVARRO, M , (2008) THE PHARMACOLOGY OF THE ENDOCANNABINOID SYSTEM: FUNCTIONAL AND STRUCTURAL INTERACTIONS WITH OTHER NEUROTRANSMITTER SYSTEMS AND THEIR REPERCUSSIONS IN BEHAVIORAL ADDICTION.ADDICTION BIOLOGY. VOL. 13. ISSUE 2. P. 160 -187 | 134 | 74% | 58 |
9 | SOLINAS, M , YASAR, S , GOLDBERG, SR , (2007) ENDOCANNABINOID SYSTEM INVOLVEMENT IN BRAIN REWARD PROCESSES RELATED TO DRUG ABUSE.PHARMACOLOGICAL RESEARCH. VOL. 56. ISSUE 5. P. 393 -405 | 136 | 76% | 39 |
10 | FERNANDEZ-RUIZ, J , HERNANDEZ, M , RAMOS, JA , (2010) CANNABINOID-DOPAMINE INTERACTION IN THE PATHOPHYSIOLOGY AND TREATMENT OF CNS DISORDERS.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 16. ISSUE 3. P. E72 -E91 | 128 | 69% | 56 |
Classes with closest relation at Level 1 |